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Eugene M. Langan III, MD, and Jerry R. Youkey, MD, Greenville, SC
Background: Percutaneous transluminal angioplasty (PTA), although not the traditional therapy, seems to be a safe
alternative for patients with critical limb ischemia who are believed to be unsuitable candidates for open surgery.
However, the efficacy of PTA in this setting has not been analyzed. The purpose of this study was to compare the
outcomes of PTA for limb salvage with outcomes of major limb amputation in physiologically impaired patients believed
to be unsuitable for open surgery.
Methods: From a prospective vascular registry, 314 patients (183 underwent amputation, and 131 underwent complex
PTA for limb salvage) were identified as physiologically impaired or unsuitable for open surgery. This was defined as
having at least one of the following: functional impairment (homebound ambulatory or transfer only), mental
impairment (dementia), or medical impairment (two of the following: end-stage renal disease, coronary artery disease,
and chronic obstructive pulmonary disease). Patients undergoing PTA were compared with patients undergoing
amputation by examining the outcome parameters of survival, maintenance of ambulation, and maintenance of
independent living status. Parameters were assessed by using Kaplan-Meier life-table curves (log-rank test and 95%
confidence intervals [CIs]) and hazard ratios (HRs) from the Cox model.
Results: PTA resulted in a 12-month limb salvage rate of 63%. Thirty-day mortality was 4.4% for the amputation group
and 3.8% for the PTA group. After adjustment for age, race, diabetes, prior vascular procedure, dementia, and baseline
functional status, PTA patients had significantly lower rates of ambulation failure (HR, 0.44; P  .0002) and loss of
independence (HR, 0.53; P  .025) but had significantly higher mortality (HR, 1.62; P  .006) than amputees.
However, when life tables were examined, the maintenance of ambulation advantage lasted only 12months (PTA, 68.6%;
95% CI, 59.6%-77.7%; amputation, 48%; 95% CI, 40.4%-55.5%) and was not statistically significant at 2 years (62.2%
[95% CI, 48.8%-71.5%] and 44% [95% CI, 35.8%-52.2%], respectively). Maintenance of independent living status
advantage lasted only 3 months, with no statistically significant difference at 2 years (PTA, 60.5%; 95% CI,
45.4%-75.6%; amputation, 52.6%; 95% CI, 40.4%-64.9%). Although mortality was high in both cohorts, patients
who underwent amputation had a survival advantage for all time intervals examined (at 2 years: PTA, 29%; 95% CI,
19.9%-38.1%; amputation, 48.1%; 95% CI, 39.2%-56.9%).
Conclusions: Patients who present with critical limb ischemia and physiologic impairments that preclude open surgery
seem to have comorbidities that blunt any functional advantage achieved after PTA for limb salvage. PTA in this setting
affords very little benefit compared with amputation alone. (J Vasc Surg 2007;45:304-11.)As the population ages, the overall physiologic condi-
tion of patients presenting with critical limb ischemia (CLI)
will undoubtedly become more debilitated. Consequently,
the degree of physiological impairment will influence the
type of treatment offered. Patients who are bedridden and
nonambulatory will continue to receive expectant therapy
and primary limb amputation when necessary. Patients with
milder physiologic impairment, capable of realizing benefit
from limb salvage, will most likely receive the preferred
procedure for multisegmental arterial disease: open surgical
bypass. However, there is a growing number of patients
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304who, although functional, are significantly debilitated and
have substantial physiologic impairment. Despite the pres-
ence of CLI, these patients possess physical debilities that
most vascular surgeons would consider contraindications
to open bypass surgery. Examples include patients who
present withmultiplemedical comorbidities and limited life
expectancy; patients with minimal ambulatory capability,
who function independently by using their limbs for short
distance walking or for transfer but depend on a wheelchair
for the activities of daily living; and patients who have
functional dementia but do not require institutionalization.
These individuals pose a dilemma to the practicing vascular
surgeon. If left untreated, the CLI will most likely progress
to limb loss and further disability.1 However, these patients
usually do not have the physiologic reserve for meaningful
functional recovery after open surgical bypass even when
it is technically successful. Although this is a subjective
judgment, these patients are believed to be too sick for a
large operation and are, simply stated, unsuitable for
open surgery.
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has gained increasing acceptance as an alternative to open
bypass in various clinical situations. For example, most
would consider the initial best interventional treatment for
claudication to be percutaneous transluminal angioplasty
(PTA) if technically feasible.2 Indeed, some have advocated
angioplasty as an acceptable treatment for certain cases of
CLI.3-14 The most obvious advantage to this minimally
invasive therapy is the low morbidity and mortality associ-
ated with treatment.3,15,16 Considering this, peripheral
angioplasty would seem a logical alternative for the afore-
mentioned patient group with CLI who are unsuitable for
open bypass. Most of these patients are capable of surviving
an angioplasty procedure. Furthermore, the poor long-
term patency of angioplasty when used for CLI usually has
little relevance to these patients. Consequently, clinical
expectations in these cases are limited, and success is usually
measured as the ability to improve peripheral circulation
enough to allow healing and limb salvage. Goals are gen-
erally geared toward maintaining the functional status quo.
Angioplasty creates no leg incisions that might jeopardize
the level of subsequent limb amputation, and thus this
would seem to be a no-lose proposition for patients with
amenable arterial lesions. Despite this logic, it can be ar-
gued that peripheral angioplasty is an expensive modality in
a financially failing health care system and that it should be
used only if clinical benefit can be demonstrated. In reality,
functional benefit after treatment with PTA for limb salvage
in debilitated patients believed unsuitable for open surgery
has not been examined. Therefore, the purpose of this
study was to answer this clinical question: When a patient
with CLI is judged unsuitable for open surgery, will he/she
alternatively achieve functional benefit from a treatment
strategy using PTA and aggressive wound management to
attain limb salvage?
METHODS
To examine the proposed study question, we retrospec-
tively identified a group of patients who were deemed
unsuitable for open surgery and who underwent PTA of the
lower extremities for CLI. To measure the success of this
treatment, the functional outcomes of these patients were
compared with those of a cohort of medically and physio-
logically impaired patients who had undergone primary
major limb amputation consequent to CLI without vascu-
lar intervention before amputation. Functional end points
measured included survival and postoperative maintenance
of ambulatory and independent living status as compared
with the preoperative state.
The lower extremity database and data collection
process. Since 1992, a prospective vascular registry of all
cases performed on the Vascular Surgery Service at Green-
ville Hospital System University Medical Center has been
maintained. However, since 1998, the year our endovascu-
lar program was initiated, a subset of patients with lower
extremity peripheral arterial disease has been closely fol-
lowed up with Institutional Review Committee approval.
Each procedure is entered on an Excel spreadsheet (Mi-crosoft Corp, Redmond, Wash). Preoperative demograph-
ics are obtained at presentation and entered into the data-
base. Functional information (ambulatory status and living
situation) are also included. Follow-up information has
been recorded at each postprocedure visit. The type of
treatment (PTA, open bypass, or amputation) is left to the
judgment of the treating physician. For patients receiving
open infrainguinal bypass, minimum follow-up consists of
noninvasive duplex scan–derived graft flow velocities at 1
month, every 3 months for the first 18 months, and then
every 6 months thereafter. Patients with endovascular in-
tervention are followed up at a minimumwith a patient visit
and a noninvasive vascular study at 1 month and then at
6-month intervals thereafter. The database (to include
functional information) is updated at each visit. Also, the
database has been scrutinized each summer by independent
research workers completing missing data points (especially
with amputees) or missing patients. Sources used to attain
follow-up include the hospital computerized Lifetime Clin-
ical Record, the computerized radiology Picture Archiving
Communication System (PACS), and the online obituary
services of all statewide newspapers.
To date, more than 1700 revascularizations and 700
major lower extremity amputations have been entered into
the database, and patients have been followed up for func-
tional outcome and living status. All endovascular proce-
dures entered into the registry were performed by vascular
surgeons or an interventional-trained vascular internist.
Using the above-described database, we identified 314
patients with CLI (rest pain or tissue loss with an ankle
pressure50-70 mmHg or toe pressure30-50 mmHg)
who were medically, functionally, or mentally unsuitable
for open vascular surgery and who underwent either PTA
or major limb amputation. For the purpose of this study, all
surgically unsuitable patients were defined as (1) medically
impaired (at least two of the following active clinical diag-
noses: dialysis-dependent end-stage renal disease and/or
high-risk coronary artery disease as defined by the Eagle
criteria17 and/or clinically treated chronic obstructive pul-
monary disease), (2) functionally impaired (homebound
ambulatory [defined as being able to walk around the home
with assistance but unable to actively walk outside the
home] or nonambulatory transfer only [defined as using
the lower extremities to help transfer from wheelchair to
bed or wheelchair to commode only]), or (3) mentally
impaired (defined as having clinical dementia not requiring
institutionalization). In our database, independent living
status is classified as independent (able to perform activities
of daily living without assistance, whether it be in an
independent domicile or in an assisted-living environment)
or nonindependent. Ambulatory status is classified as am-
bulatory out of home, homebound ambulatory, nonambu-
latory transfer only, or bedridden. When considering the
functional state before surgery, the status was graded as
according to baseline ambulatory classification before the
onset of ischemia. Impaired functional status was, there-
fore, usually a consequence of pre-existing chronic medical
conditions such as arthritis or advanced age and not that of
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study, all patients who were bedridden and nonindepen-
dent at initial presentation were excluded from analysis.
With these definitions, there were 63 medically impaired
patients (amputation, n 34; PTA, n 29), 226 function-
ally impaired patients (amputation, n  119; PTA, n 
107), and 129mentally impaired patients (amputation, n
90; PTA, n  39). Multiple causes of impairment were
present in 104 patients.
Of the 314 patients, 183 underwent 206 major limb
amputations (90 above-knee amputations, 6 through-
knee amputations, 64 below-knee amputations, and 23
bilateral amputations), and 131 underwent PTA of 148
lower extremities for limb salvage. Of the procedures per-
formed, 47 were performed on the aortoiliac vessels, and
101 were performed on the infrainguinal vessels. The pat-
tern of aortoiliac occlusive disease treated was classified as
Trans-Atlantic Inter-Society Consensus (TASC) A or B
(n  32) and TASC C or D (n  15). The pattern of
infrainguinal occlusive disease treated was classified as
TASCA or B (n 44) and TASCC or D (n 57). Primary
stents were generally used in cases for which stand-alone
angioplasty resulted in arterial dissection or residual steno-
sis and a measurable pressure gradient. All 206 amputees
experienced successful clinical healing of their amputation
site, and all 148 angioplasty procedures were believed to be
technically successful (defined as an adequate cosmetic
result at the end of treatment and either an increase of at
least 0.15 in posttreatment ankle-brachial index or an in-
crease in great toe pressure of at least 15 mm Hg). A
demographic comparison of amputees vs patients undergo-
ing endovascular PTA is shown in the Table.
For the purpose of this study, preoperative ambulatory
and independent living status were compared with postop-
erative ambulatory and independent living status. Deterio-
ration in ambulatory status was defined as a change from
the preoperative ambulatory classification (ie, from ambu-
latory out of home to homebound ambulatory or to
nonambulatory transfer only). Similarly, deterioration in
independent living status was defined as a permanent
change in status from living independently to living non-
independently. Temporary admission to an assisted living
or a rehabilitation facility for the purpose of recovery was
not counted as deterioration in living status. Within the
314-patient cohort, there were individuals who were clas-
sified as nonindependent but ambulatory before interven-
tion or amputation (n  98; 76 who underwent amputa-
tion and 22 who underwent PTA). These patients were
included in the analysis for survival and maintenance of
ambulatory status after treatment but were excluded in the
analysis for maintenance of independent living status.
Statistical analysis. Kaplan-Meier survival curves were
used to assess limb salvage, survival, maintenance of ambu-
latory status, and maintenance of independent living status
over time. The proportional hazards assumption was tested
for each plot and found to be appropriate. The log-rank test
was used to assess differences in the curves between the two
study groups, which also underwent variable adjustment(age, race, presence of diabetes, prior vascular procedure,
dementia, and baseline functional status) by using a Cox
proportional hazards model. Hazard ratios (HRs) and 95%
confidence intervals from the final model were used to
describe the time risk. All analyses were conducted by using
SAS software (version 8; SAS Institute, Cary, NC). P values
.05 were considered indicative of statistical significance.
RESULTS
Follow-up was complete for all 314 patients (amputa-
tion group: median, 283 days; average, 459 days; PTA
group: mean, 311 days; median, 386 days). The 30-day
Table. A demographic comparison of 314 patients
unsuitable for open surgery who underwent either PTA





(n  131) P value
Age (y)
65 68 (37.2) 20 (15.3)
65-79 75 (41.0) 63 (48.1) .0001*
80 40 (21.8) 48 (36.6)
Sex
Male 99 (54.1) 69 (52.7) .8027
Female 84 (45.9) 62 (47.3)
Race
White 118 (64.5) 101 (77.1) .0164*
Black/Hispanic 65 (35.5) 30 (22.9)
Diabetes mellitus
No 53 (29.0) 52 (39.7) .0468*
Yes 130 (71.0) 79 (60.3)
Smoke
No 79 (43.2) 52 (39.7) .5381
Yes 104 (56.8) 79 (60.3)
ESRD
No 108 (59.0) 83 (63.4) .4370
Yes 75 (41.0) 48 (36.6)
Prior vascular procedure
No 80 (43.7) 92 (70.2) .0001*
Yes 103 (56.3) 39 (29.8)
Living status
Independent 107 (58.5) 109 (83.2) .0001*
Nonindependent 76 (41.5) 22 (16.8)
CAD
No 69 (37.7) 40 (30.5) .1881
Yes 114 (62.3) 91 (69.5)
Dementia
No 93 (50.8) 92 (70.2) .0006*
Yes 90 (49.2) 39 (29.8)
Functional
Ambulatory 64 (35.0) 24 (18.3) .0012*
Impaired 119 (65.0) 107 (81.7)
Medical impairment
No 149 (81.4) 102 (77.9) .4376
Yes 34 (18.6) 29 (22.1)
Single impairment 130 (71.0) 93 (71.0) .9929
Multiple Impairments 53 (29.0) 38 (29.0)
PTA, Percutaneous transluminal angioplasty; ESRD, end-stage renal dis-
ease; CAD, coronary artery disease.
Factors significantly associated with treatment were age, race, diabetes
mellitus, prior vasc procedure, preoperative living status, dementia, and
preoperative functional status.mortality was 4.4% for the amputation group and 3.8% for
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foot care was associated with a 63% 12-month limb salvage
rate as determined by Kaplan-Meier life-table analysis.
Overall, 42 patients (6 ambulatory out of home, 28 home-
bound ambulatory, and 8 nonambulatory transfer only) in
the PTA group subsequently received a major limb ampu-
tation at some point during the study. Five of these patients
ambulated with the use of a prosthetic device after surgery.
Figures 1, 2, and 3 show comparisons by using Kaplan-
Meier life-table analysis of amputation vs PTA for overall
survival, maintenance of ambulatory status, and mainte-
nance of independent living status, respectively. There was
a statistically significant survival advantage for patients un-
dergoing major limb amputation when compared with
patients receiving PTA (48% vs 29% at 24 months; log-
rank; P  .0013). The median survival time for patients
undergoing amputation was 24 months, compared with 14
months for those undergoing PTA. There was a statistically
significant advantage in maintenance of ambulatory status
for patients undergoing PTA when compared with patients
receiving major limb amputation (60.2% vs 44% at 24
months; log-rank; P .0001). Likewise, there was a statis-
tically significant advantage in maintenance of independent
living status for patients undergoing PTA when compared
with patients receiving major limb amputation (60.5% vs
52.6% at 24 months; log-rank; P  .046).
When stratifying the type of treatment (amputation vs
PTA) by the type of physiologic impairment (functional
impairment vs medical impairment vs mental impairment),
functionally andmentally impaired amputees demonstrated
a survival advantage when compared with PTA patients
(44.4% vs 30.1% at 24 months [log-rank; P  .0203] and
47.5% vs 36.7% at 24 months [log-rank; P  .0140],
respectively). However, there was no statistically significant
survival advantage for either treatment group for medically
impaired patients (62.6% [amputation] vs 51.7% [PTA] at
Fig 1. A survival comparison of 314 patients unsuitable for open
surgery who underwent percutaneous transluminal angioplasty
(PTA) or primary amputation (amp) for critical limb ischemia.CI,
Confidence interval.24 months; log-rank; P  .0668). Although functionallyimpaired PTA patients demonstrated an advantage inmain-
tenance of ambulatory status compared with amputees
(60.8% vs 44.4% at 24 months; log-rank; P .0003), there
was no statistically significant advantage in maintenance of
ambulation for medically (43% [amputation] vs 58.2%
[PTA] at 12 months; log-rank; P  .1463) or mentally
(43.5% [amputation] vs 54.5% [PTA] at 24 months; log-
rank; P  .0625) impaired patients. Likewise, although
functionally impaired PTA patients demonstrated an ad-
vantage in maintenance of independent living status com-
pared with amputees (59.9% vs 42.1% at 24 months; log-
rank; P  .0043), there was no statistically significant
advantage in maintenance of independence for medically
(57.1% [amputation] vs 67.1 [PTA] at 12 months; log-
rank; P  .5618) or mentally (62.1% [amputation] vs
50.9% [PTA] at 12 months; log-rank; P .4794) impaired
Fig 2. A comparison of maintenance of ambulation in 314 pa-
tients unsuitable for open surgery who underwent percutaneous
transluminal angioplasty (PTA) or primary amputation (Amp) for
critical limb ischemia. CI, Confidence interval.
Fig 3. A comparison of maintenance of independent living in 314
patients unsuitable for open surgery who underwent percutaneous
transluminal angioplasty (PTA) or primary amputation (Amp) for
critical limb ischemia. CI, Confidence interval.patients.
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geneity in the demographics of patients grouped by treat-
ment (amputation vs PTA). Considering this, Cox propor-
tional hazards models were used to adjust the treatment
outcomes for age, race, diabetes mellitus, prior vascular
intervention, dementia, and baseline functional status. Af-
ter adjustment, the type of treatment was the most consis-
tent predictor of outcome and was statistically significant
for every outcome parameter measured. PTA was the only
independent predictor of mortality (HR, 1.62; P .0064).
Diabetes mellitus and type of treatment were the only
statistically significantly independent predictors of ambula-
tion deterioration. In the latter case, PTA patients had
significantly lower rates of ambulatory failure (HR, 0.44;
P  .0002) when compared with patients undergoing
amputation. The presence of dementia, impaired preoper-
ative functional status, and type of treatment were all
statistically significant independent predictors of living sta-
tus deterioration. Regarding treatment, PTA patients had
significantly lower rates of living status deterioration (HR,
0.53; P  .0245) compared with patients undergoing
amputation.
Finally, a Kaplan-Meier comparison of cumulative sur-
vival, cumulative maintenance of ambulation, and cumula-
tive maintenance of independent living status rates showed
that, although there was an advantage in maintenance of
ambulatory status and maintenance of independent living
status in the patient group treated with PTA, the increment
of benefit was quite modest. When considering mainte-
nance of ambulation, the benefit derived from PTA lasted
only 12 months (Fig 2), and when considering mainte-
nance of independent living status, the benefit derived from
PTA lasted only 3 months (Fig 3). After 1 year, the two
treatments seemed to have equivalent outcomes. In con-
trast, these short-lived benefits of functional outcome with
PTA seemed to be offset by a more sustained clinical
survival disadvantage for patients undergoing percutaneous
treatment and aggressive limb salvage (Fig 1).
DISCUSSION
There is a growing body of literature advocating an
expanded role for PTA in the treatment of CLI.3-14 Most of
the studies report small numbers of patients who, for
usually technical reasons, are not candidates for open sur-
gery. Patients usually are cited as having no distal arterial
targets for bypass or no veins for a conduit. The end points
of success are typically quite broad and include healing of
ischemic ulcers, resolution of rest pain, improvement of the
ankle-brachial index, or healing of a minor amputation site.
One contemporary series recently reported data by using
the reporting standards of the Society for Vascular Surgery
and the International Society for Cardiovascular Surgery in
which patency data and limb salvage were measured.5 In
summarizing the reported data, limb salvage and, more
commonly “clinical success rates” ranged from 55% to 90%.
It is interesting to note that in essentially every report,
historical controls are implied.3-6,8-11,13 The clinical out-
comes achieved with PTA are typically compared with theexpected results after bypass. The conclusions are fairly
consistent. Each report usually concedes that although
outcomes are not as good as those with surgical bypass,
they are usually better than expected and are certainly
better than doing nothing. What is implied in “doing
nothing” is, of course, primary limb amputation. The lim-
itations of all of these studies are the same. The patients
included in the trials are usually heterogeneous, and the
clinical successes, when they occur, are generally attributed
to the treatment by PTA. In reality, because the studies
usually have no real controls, successes may occur with
simple medical management alone and no PTA. Most of
the reports also imply, again with no proof, that the out-
comes reported are superior to outcomes that occur after
major limb amputation.
Our studymade no such assumptions. It looked at PTA
in patients with CLI determined to be unsuitable for open
surgery and measured meaningful functional outcomes:
survival, the ability to maintain preoperative ambulation
status, and the ability tomaintain preoperative independent
living status. These end points were chosen because they
could be measured against outcomes of doing nothing—
namely, primary amputation. In trying to answer a simple,
but important, question—does PTA benefit patients with
CLI who are unsuitable for open bypass?—we objectively
defined characteristics that most would accept as being
consistent with surgical unsuitability and then retrospec-
tively studied functional outcomes from our prospective
database after treatment. Despite being able to salvage
most limbs, we found 3-year maintenance of ambulatory
status and maintenance of independent living status to be
55% and 51%, respectively. Survival was a sobering 18% at
36 months. To provide a frame of reference, we compared
these data not with outcomes achieved from a comparable
cohort of medically and physiologically impaired patients
after successful bypass, but with a similar population that
underwent primary major limb amputation. As might have
been anticipated, we found that after adjusting for demo-
graphic differences in the populations, patients treated with
PTA had superior rates for maintenance of ambulation and
independent living status compared with amputees. What
was not anticipated was that these advantages were very
short lived: only 3 months for maintenance of indepen-
dence and 1 year for maintenance of ambulation. Taking a
critical perspective, therefore, it can be concluded that after
1 year, PTA used to attempt limb salvage afforded no more
functional benefit than primary limb amputation alone.
Given these findings, the treatments after 1 year seem to be
equivalent.
However, an additional unanticipated finding oc-
curred: patients who underwent PTA and treatment for
aggressive limb salvage experienced a significant survival
disadvantage when compared with amputees. This disad-
vantage occurred essentially across all time points mea-
sured. The reason for these findings is unclear. It was
originally speculated that there may have been some type of
selection bias inherent to the retrospective design of the
study. However, when adjusting for all other factors in the
JOURNAL OF VASCULAR SURGERY
Volume 45, Number 2 Taylor et al 309Cox model, type of treatment was the most clinically and
statistically significant variable found to explain the survival
difference. Thus, we are left to believe that these findings
are real. In these cases, patients often had chronic foot
wounds associated with their chronic ischemia. Prolonged
wound care was usually necessary after PTA to achieve limb
salvage. This often resulted in repeat doctor visits, recurrent
bouts of cellulitis, and multiple rounds of antibiotics. The
clinical stress incurred as a result of this treatment course,
no doubt, may have taken its physiologic toll on our
debilitated patients. It therefore can be postulated that
poorer long-term survival was the result of this chronic
illness and treatment. Regardless of the cause, these find-
ings suggest that aggressive limb salvage comes at a cost not
previously realized.
In this study, we chose not to emphasize results at-
tained by subgroup analysis. Surely critics will cite that it is
unfair to compare patients with technically focal arterial
lesions (TASC A or B) with patients with technically com-
plex arterial lesions (TASC C or D) or patients who attain
limb salvage with patients who eventually require amputa-
tion or even patients who are able to achieve a below-knee
amputation with patients who undergo above-knee ampu-
tation.We concede that theremay be subgroups in the PTA
cohort that performed superior to subgroups in the ampu-
tation cohort. Also, we concede that a superior 12-month
maintenance of ambulation may be significant for this
population with limited life expectancy. However, we
chose to approach this from the perspective of the clinician
at the bedside who is forced to make a clinical decision as to
the type of therapy to be performed given the results of the
physical examination and vascular laboratory study ob-
tained. The physician usually does not have the luxury of
knowing into which subgroup this patient might later fall.
The surgeon must decide whether the next step in the
process is to proceed with an arteriogram and possible
catheter-based intervention or not. What this study dem-
onstrated was that, when taken in aggregate, patients un-
suitable for open surgery had physiologic comorbidities
that offset any possible functional benefit achieved by PTA
for limb salvage. Although further study examining factors
associated with successful outcome, including the anatomic
pattern of disease, may be helpful, PTA resulted in no
functional advantage to primary amputation alone. The
implications of these findings are obvious to the clinician at
the bedside of the physiologically impaired patient.
We found the results of this study to be enlightening.
We have moderated our enthusiasm for percutaneous in-
tervention in the debilitated patient. This is particularly true
in the cohort of patients who are functionally impaired.
Whereas traditional wisdom has recommended pursuit of
an aggressive course of limb salvage for patients who use
their limbs only to ambulate around the home or to transfer
from chair to bed, the findings of this report suggest that
early amputation may provide a better long-term outcome.
Further study is needed before a recommendation to aban-
don PTA for all patients with functional, medical, or mental
impairments can be accepted. However, this study makes itclear that PTA should be used quite selectively. Frank
discussion with families should occur in which realistic
goals and expectations with a clear emphasis on palliation
should be clearly outlined and understood before any treat-
ment. Our findings suggest that major limb amputation is
not only reasonable palliation, but also better therapy in
some instances.
In summary, patients who are physiologically unsuit-
able for surgery and who present with CLI have a very
modest functional advantage after treatment with PTA
compared with patients undergoing primary lower extrem-
ity amputation—an advantage that lasts no longer than a
year and is offset by a sustained and significant survival
disadvantage. From this, it can be postulated that these
patients have medical comorbidities that blunt any poten-
tial functional advantage achieved by limb salvage, regard-
less of the method used for revascularization. According to
these findings, we conclude that PTA should not routinely
be used for patients with CLI who are medically and
physiologically unsuitable for open bypass.
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The Greenville group has addressed an important issue con-
cerning patients with critical limb ischemia (CLI). All would agree
that, when possible, ambulatory and functional patients with CLI
should undergo revascularization for limb salvage and that de-
mented, nonambulatory, nursing home–confined patients with
fixed contractures should undergo primary major limb amputa-
tion. An increasingly common problem is what to do with the frail
patient who fits somewhere in the middle of these two extremes of
the CLI patient spectrum. Many practices have moved toward
endoluminal therapy for such patients, on the basis of the yet-
unproven but logical premise that percutaneous therapy, although
less durable, may be less morbid and still permit limb salvage for
patients with limited life expectancies without incurring excessive
risk.
The authors conclude, on the basis of their nonrandomized,
retrospective study, that CLI patients who appear “physiologically
unsuitable for surgery have a very modest functional advantage
after treatment with PTA [percutaneous transluminal angioplasty]
compared to patients undergoing primary amputation” and that
“PTA should not be routinely employed for patients with CLI who
are medically and physiologically unsuitable for bypass.” Although
this is partially correct, I believe that the authors overstate their
case and fail to consider important factors needed to make a
decision in such patients.
The authors actually report that “there was a statistically
significant advantage in maintenance of ambulatory status for
patients undergoing PTA when compared to patients undergoing
primary amputation (60.2% versus 44% at 24 months, P .001).”
PTA patients also exhibited a significant advantage in maintenance
of independent living status at 2 years (60.5% vs 52.6%; P .046)
and lower rates of ambulatory failure (P .002) and lower rates of
living status deterioration (P  .025) than primary amputees. An
alternative interpretation of the authors’ own data, then, would be
that for whatever time frail CLI patients have left in the world, PTA
is in fact beneficial with respect to maintenance of ambulatory and
independent living status but that in such patients who actually live
more than 2 to 3 years, the benefits wane. The cost of PTA in these
patients was an apparently increased mortality compared with
primary amputation, but the two groups were not randomized and
differed in several important respects (table 1). Lack of random-
ization resulted in major differences between the PTA and primary
amputation groups; the most important difference was that nearly
twice as many amputation patients (56.3%) as PTA patients
(29.8%) had undergone previous vascular reconstruction (P 
.0001). The obvious inference is that the majority of patients in thelarization attempts (and also survived those attempts), whereas the
PTA group more likely included the truly physiologically and
functionally impaired and not just those with “anatomic impair-
ment” (no conduit, no outflow, and so on). The 4.4% mortality
rate for amputees is also much lower than expected mortality rates
for major limb amputation in high-risk patients and leads one to
question their degree of physiologic impairment.
What factors need further study? First, the patients should
have been stratified both by Trans-Atlantic Inter-Society Consen-
sus (TASC) classification and degree of ischemia. TASC classifica-
tions for aortoiliac and infrainguinal disease are clear-cut, and one
would expect interventions for proximal and A/B lesions to be
simpler and more durable than more distal or complex (C/D)
interventions. Certainly the authors would not deny a frail patient
presenting with a small, nonhealing toe ulcer an iliac angioplasty
and stent for a 90% TASC A lesion. However, for an unsuitable
surgical candidate with complex infection extending into the fore-
foot and multilevel TASC C/D disease, primary amputation may
be the better part of valor. The authors did not report how many
subsequent foot debridements and local amputations were re-
quired to achieve limb salvage. This factor—repeated infections
and debridements after successful PTA—may have been the straw
that broke the camel’s back, and not the PTA itself. Such consid-
erations may have contributed to the reported 3-year survival of
only 18% in PTA patients compared with 33% in primary amputees.
Unfortunately, CLI is somewhat of a black hole; we still lack clear
definitions of degree of ischemia (trivial nonhealing toe ulcer,
simple toe gangrene, extensive forefoot necrosis, heel necrosis,
osteomyelitis, and so on), and the authors admittedly provided no
clinical information concerning the patients’ presentation. With-
out examining each patient to assess the degree of difficulty of
proposed limb-salvage efforts, it is impossible to interpret the data
in a meaningful way.
The authors have appropriately recognized that treatment of
the frail patient with CLI who is not believed to be an open-
surgical candidate is complex; injudicious PTA and multiple ag-
gressive foot debridements to effect limb salvage attempts at all
costs are unwarranted. However, we still do not have enough data
to deny all such patients revascularization. The issues facing the
vascular surgeon are nearly insurmountable and will likely always
require careful clinical judgment and individualized care. In addi-
tion to the numerous physiological, psychological, and social fac-
tors that require consideration, the complexity and expected dura-
bility of the intervention, as well as the degree and extent of
forefoot infection and ischemia, will need to be carefully assessed
before embarking on amputation or revascularization. A third
